India Confronts a Silent Crisis: Understanding the WHO Report on Rising Hepatitis Deaths

The global health landscape has been recently shaken by the World Health Organization’s (WHO) 2024 Global Hepatitis Report, which paints a sobering picture of a growing public health emergency. Despite advancements in medical technology and the availability of affordable treatments, viral hepatitis remains one of the leading causes of death worldwide. India, unfortunately, finds itself at the epicenter of this crisis. According to the report, India is among the countries with the highest burden of hepatitis, contributing significantly to the global mortality rate. With over 1.3 million deaths recorded globally in the past year, the urgency to address this “silent killer” has never been greater.

Viral hepatitis is an inflammation of the liver caused by a variety of infectious viruses and non-infectious agents. While there are five main strains—A, B, C, D, and E—the WHO report highlights that Hepatitis B and C are responsible for more than 95% of all hepatitis-related deaths. These two strains often lead to chronic infections that can persist for decades without symptoms, eventually culminating in liver cirrhosis or primary liver cancer. For India, a nation with a vast and diverse population, the challenges of screening, diagnosis, and treatment remain monumental obstacles in the path toward the WHO’s goal of eliminating hepatitis by 2030.

The Magnitude of the Global Hepatitis Crisis

The 2024 WHO report reveals a startling paradox: while our ability to treat and prevent hepatitis has improved, the number of deaths is actually on the rise. In 2019, the global death toll stood at 1.1 million; by 2024, that number climbed to 1.3 million. This increase suggests that the global response is not keeping pace with the rate of new infections and the aging population of those already infected. The report underscores that viral hepatitis now kills as many people as tuberculosis, yet it receives significantly less funding and public attention.

The vast majority of these deaths are preventable. Hepatitis B is preventable through a highly effective vaccine, and Hepatitis C is now curable with short-term antiviral treatments. However, the gap lies in “access.” In many parts of the world, including Southeast Asia and Africa, the infrastructure for mass screening and affordable medication is lacking. The WHO emphasizes that unless there is a radical shift in how governments prioritize liver health, the death toll will continue to climb, particularly in high-burden countries like India.

India at the Epicenter: Decoding the WHO Findings

India’s position in the WHO report is particularly concerning. The country accounts for a substantial portion of the global chronic hepatitis B and C infections. The high prevalence in India is attributed to several factors, including historical gaps in vaccination coverage, unsafe injection practices in healthcare settings, and a lack of awareness regarding the routes of transmission. In many rural and semi-urban areas, hepatitis is often diagnosed only when it has reached an advanced stage, such as end-stage liver disease or hepatocellular carcinoma (liver cancer).

The report points out that India is one of the ten countries that together account for nearly two-thirds of the global burden of hepatitis B and C. This high concentration means that the global success of hepatitis elimination programs depends heavily on the progress made within India’s borders. While the Indian government has launched the National Viral Hepatitis Control Program (NVHCP), the scale of the challenge requires more aggressive community-level interventions and a massive increase in testing rates to identify the millions of “missing” cases.

The Lethal Duo: Why Hepatitis B and C are the Primary Culprits

Why do Hepatitis B and C account for over 95% of deaths? The answer lies in their ability to become chronic. Unlike Hepatitis A and E, which are typically acute illnesses that the body clears on its own, B and C can stay in the system for a lifetime. This persistence leads to a slow but steady destruction of liver tissue.

• Hepatitis B: This virus is often transmitted from mother to child during birth or through contact with infected blood and body fluids. Because it can be asymptomatic for years, many carriers unknowingly pass the virus to others while their own liver undergoes progressive scarring.
• Hepatitis C: Primarily blood-borne, this virus is frequently spread through unsterile medical equipment, blood transfusions before rigorous screening was implemented, and shared needles. Hepatitis C is often called the “stealth virus” because patients may feel perfectly healthy until their liver is 80% damaged.

The WHO report highlights that the synergy between these viruses and other lifestyle factors, such as alcohol consumption and non-alcoholic fatty liver disease (NAFLD), accelerates liver damage. In India, where metabolic disorders are on the rise, the combination of viral hepatitis and fatty liver is proving to be a deadly cocktail.

The Barrier to Eradication: Why Mortality Rates Remain Stubbornly High

If cures and vaccines exist, why are people still dying in such high numbers? Several systemic barriers prevent effective control of the disease. First is the “Diagnostic Gap.” Globally, only about 13% of people living with chronic hepatitis B have been diagnosed, and for hepatitis C, the figure is around 36%. In India, these percentages are estimated to be even lower in certain demographics. Without a diagnosis, there is no treatment, and the disease continues to progress.

Second is the “Treatment Gap.” Even after diagnosis, the cost of long-term medication for Hepatitis B and the bureaucratic hurdles in accessing “Direct-Acting Antivirals” (DAAs) for Hepatitis C can be prohibitive. Furthermore, social stigma remains a significant deterrent. Many individuals fear being ostracized by their communities or face discrimination in the workplace if their hepatitis status is revealed, leading them to avoid testing altogether.

Recognizing the Symptoms: When to Consult a Specialist

One of the most dangerous aspects of viral hepatitis is its silence. However, as the disease progresses, certain red flags may appear. It is crucial for individuals, especially those in high-risk categories, to monitor their health for the following symptoms:

• Chronic fatigue and unexplained weakness.
• Jaundice (yellowing of the skin and the whites of the eyes).
• Dark-colored urine and pale or clay-colored stools.
• Persistent abdominal pain, particularly in the upper right quadrant.
• Loss of appetite and unexplained weight loss.
• Nausea and frequent vomiting.

If you experience these symptoms, or if you have a history of blood transfusions, tattoos from uncertified parlors, or unprotected contact, it is imperative to seek a blood test. Early detection is quite literally the difference between life and death.

The Power of Prevention: Vaccines and Safe Practices

Prevention is the most effective tool in India’s arsenal against hepatitis. The WHO report emphasizes that the hepatitis B vaccine is 95% effective in preventing infection and the subsequent development of chronic disease and liver cancer. In India, the inclusion of the Hep B vaccine in the Universal Immunization Programme (UIP) has been a major step forward, but “catch-up” vaccinations for adults remain underutilized.

For Hepatitis C, where no vaccine exists, prevention focuses on harm reduction and safe medical practices. This includes ensuring that all blood products are screened using modern nucleic acid testing (NAT), using only sterilized or disposable needles, and practicing safe intimacy. Public health campaigns must also focus on educating traditional practitioners and barbers about the risks of re-using blades and equipment.

Living with Hepatitis: Management and Lifestyle Interventions

For those already diagnosed with chronic hepatitis, the focus shifts to management and preventing further liver damage. Modern medicine allows patients with Hepatitis B to lead long, healthy lives with daily suppressive therapy, while Hepatitis C patients can usually be cured in 8 to 12 weeks with oral tablets. However, medical treatment must be supported by lifestyle choices.

The liver is a resilient organ, but it needs support. Patients are advised to avoid alcohol entirely, as it acts as a catalyst for viral damage. A diet rich in antioxidants, fresh vegetables, and lean proteins can help reduce oxidative stress on the liver. Maintaining a healthy weight is also vital, as obesity-related fatty liver can worsen the prognosis of viral hepatitis. Regular monitoring through fibroscans and ultrasound is necessary to detect any early signs of liver cancer, which can then be treated more effectively.

India’s National Response: A Glimmer of Hope

While the WHO report flags India as a “worst-hit” nation, it also acknowledges the efforts being made. The National Viral Hepatitis Control Program (NVHCP) aims to provide free testing and treatment to millions. This initiative is one of the largest of its kind in the world. By decentralizing care and moving it from tertiary hospitals to primary health centers, the government is attempting to bridge the access gap.

However, the report suggests that for India to meet the 2030 targets, the pace must accelerate. There needs to be a shift toward “integrated health services,” where hepatitis screening is offered alongside services for HIV, tuberculosis, and prenatal care. Empowering community health workers (ASHAs) to educate rural populations about hepatitis can also play a pivotal role in de-stigmatizing the disease and encouraging testing.

Conclusion: Taking Charge of Your Liver Health

The WHO 2024 report is a clarion call for action. The fact that 1.3 million people are dying annually from a disease that we have the tools to control is a global health failure that cannot be ignored. For Indians, the message is clear: the risk is high, but the solution is within reach. Knowledge is the first line of defense. Understanding how hepatitis spreads, getting vaccinated, and demanding safe medical practices are steps every citizen can take.

At Fittoss, we believe that health is a proactive journey. We urge our readers to prioritize liver health as much as heart or lung health. If you have never been screened for Hepatitis B or C, make it a priority during your next health check-up. By increasing awareness and breaking the silence surrounding this disease, we can collectively turn the tide and ensure that the next WHO report tells a story of recovery and hope rather than loss and neglect. Your liver performs over 500 vital functions every day; it’s time we gave it the protection it deserves.